OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
SIS58

Grupo de Inversiones Suramericana SA

Life & Health InsuranceVerified

The company maintains a capital structure with a debt-to-equity ratio of 0.35, indicating a relatively conservative leverage position compared to industry norms. Its liquidity position is characterized by a free cash flow of 1.45 trillion COP and cash and equivalents of 2.69 trillion COP, though net cash is negative after subtracting total debt. The return on equity of 9.44% and return on assets of 1.98% suggest that the company is generating returns above the industry median for ROE but below for ROA. Profitability metrics show that the company's operating income is 2.13 trillion COP and net income is 1.84 trillion COP, which are in line with the industry's preferred metrics. However, the return on assets is below the median for the industry, indicating that the company may not be utilizing its assets as efficiently as its peers. The company's geographic exposure is not explicitly detailed in the provided data, but its revenue concentration is implied to be within the Latin American region, given its name and classification. There is no specific information on segments or geographic breakdowns in the input data. The growth trajectory for the current fiscal year is not explicitly provided, but the company's operating cash flow of 4.07 trillion COP and free cash flow of 1.45 trillion COP suggest a strong cash generation capability. The capital expenditure of -333.33 billion COP indicates a reduction in capital spending, which may be a strategic move to preserve liquidity. The risk assessment highlights a medium liquidity risk and a low dilution risk. The key flag of negative net cash after subtracting total debt suggests potential liquidity constraints. The dilution risk is low, and there are no immediate signs of dilution pressure in the near term. Recent events and filings do not provide specific details in the input data, but the company's financial performance and analyst estimates suggest a stable outlook. The mean price target of 69,766.67 COP and the median price target of 68,000.00 COP indicate a generally positive sentiment among analysts, although there are no strong buy recommendations.

30-day price · SIS+100.00 (+0.2%)
Low$46000.00High$55500.00Close$48500.00As of10 May, 00:00 UTC
Profile
CompanyGrupo de Inversiones Suramericana SA
TickerSIS.CN
SectorFinancials
BusinessInsurance
Industry groupInsurance
IndustryLife & Health Insurance
AI analysis

Business. Grupo de Inversiones Suramericana SA operates in the life and health insurance sector, generating revenue primarily through insurance premiums and investment income from its substantial asset base.

Classification. The company is classified under the Life & Health Insurance industry within the Insurance business sector, with a high confidence level of 0.92 based on verified market data.

The company maintains a capital structure with a debt-to-equity ratio of 0.35, indicating a relatively conservative leverage position compared to industry norms. Its liquidity position is characterized by a free cash flow of 1.45 trillion COP and cash and equivalents of 2.69 trillion COP, though net cash is negative after subtracting total debt. The return on equity of 9.44% and return on assets of 1.98% suggest that the company is generating returns above the industry median for ROE but below for ROA. Profitability metrics show that the company's operating income is 2.13 trillion COP and net income is 1.84 trillion COP, which are in line with the industry's preferred metrics. However, the return on assets is below the median for the industry, indicating that the company may not be utilizing its assets as efficiently as its peers. The company's geographic exposure is not explicitly detailed in the provided data, but its revenue concentration is implied to be within the Latin American region, given its name and classification. There is no specific information on segments or geographic breakdowns in the input data. The growth trajectory for the current fiscal year is not explicitly provided, but the company's operating cash flow of 4.07 trillion COP and free cash flow of 1.45 trillion COP suggest a strong cash generation capability. The capital expenditure of -333.33 billion COP indicates a reduction in capital spending, which may be a strategic move to preserve liquidity. The risk assessment highlights a medium liquidity risk and a low dilution risk. The key flag of negative net cash after subtracting total debt suggests potential liquidity constraints. The dilution risk is low, and there are no immediate signs of dilution pressure in the near term. Recent events and filings do not provide specific details in the input data, but the company's financial performance and analyst estimates suggest a stable outlook. The mean price target of 69,766.67 COP and the median price target of 68,000.00 COP indicate a generally positive sentiment among analysts, although there are no strong buy recommendations.
Key takeaways
  • The company has a conservative debt-to-equity ratio of 0.35, suggesting a prudent capital structure.
  • It generates a return on equity of 9.44%, which is above the industry median.
  • The company's free cash flow of 1.45 trillion COP indicates strong liquidity.
  • The return on assets of 1.98% is below the industry median, suggesting inefficiencies in asset utilization.
  • Analysts have a generally positive outlook, with a mean price target of 69,766.67 COP.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCOP
Revenue
Gross profit
Operating income$2.13T
Net income$1.84T
R&D
SG&A
D&A
SBC
Operating cash flow$4.07T
CapEx-$333.33B
Free cash flow$1.45T
Total assets$93.15T
Total liabilities$73.65T
Total equity$19.50T
Cash & equivalents$2.69T
Long-term debt$6.73T
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$19.50T
Net cash-$4.04T
Current ratio
Debt/Equity0.3
ROA2.0%
ROE9.4%
Cash conversion2.2%
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Life & Health Insurance · cohort 15 companies
MetricSISActivity
Op margin12.3% medp25 5.6% · p75 21.6%
Net margin2.9% medp25 0.5% · p75 10.1%
Gross margin28.2% medp25 13.4% · p75 30.5%
CapEx / revenue-2.1% medp25 -8.2% · p75 -1.2%
Debt / equity35.0%27.5% medp25 4.7% · p75 66.5%above median
Observations
IR observations
Mean price target69,766.67 COP
Median price target68,000.00 COP
High price target84,800.00 COP
Low price target56,500.00 COP
Mean recommendation2.67 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count1.00
Hold count2.00
Sell count0.00
Strong-sell count0.00
Last actual EPS4,280.60 COP
Mean revenue estimate28,139,000,000,000 COP
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-24 16:49 UTC#c1ac0502
Source: analysis-pipeline (hybrid)Generated: 2026-05-29 11:01 UTCJob: db8d4fdb